Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development.
Kroeger PT Jr, Drummond BE, Miceli R, McKernan M, Gerlach GF, Marra AN, Fox A, McCampbell KK, Leshchiner I, Rodriguez-Mari A, BreMiller R, Thummel R, Davidson AJ, Postlethwait J, Goessling W, Wingert RA. Kroeger PT Jr, et al. Among authors: miceli r. Dev Biol. 2017 Aug 1;428(1):148-163. doi: 10.1016/j.ydbio.2017.05.025. Epub 2017 Jun 1. Dev Biol. 2017. PMID: 28579318 Free PMC article.
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.
Rusconi C, Barone A, Visentin A, Bianchi B, Zilioli VR, Bernardelli A, Iadecola S, Olivari E, Rossi FG, Gotti M, Cecchetti C, Puccini B, Franceschetti S, Molteni A, Steffanoni S, Marino F, Vanazzi A, Guidetti A, Merli M, Mazzon F, Marchetti A, Cellini A, Muzi C, Miceli R, Visco C, Re A, Corradini P. Rusconi C, et al. Among authors: miceli r. Leuk Lymphoma. 2025 Jan 11:1-9. doi: 10.1080/10428194.2024.2446609. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39797589
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey.
Apolone G, Costantini M, Caselli L, Bos N, Caraceni A, Ciliberto G, Couespel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Velikova G, Garin O, Gilbert A, Machiavelli A, Marzorati C, Miceli R, Pe M, Petersen MA, Tanzilli A, van Schelven F, Dantas C, Minnée-van Braak I, Pinnavaia L, Brunelli C. Apolone G, et al. Among authors: miceli r. BMC Public Health. 2024 Dec 18;24(1):3517. doi: 10.1186/s12889-024-21008-4. BMC Public Health. 2024. PMID: 39696103 Free PMC article.
Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations.
Miceli RT, Chen TY, Nose Y, Tichkule S, Brown B, Fullard JF, Saulsbury MD, Heyliger SO, Gnjatic S, Kyprianou N, Cordon-Cardo C, Sahoo S, Taioli E, Roussos P, Stolovitzky G, Gonzalez-Kozlova E, Dogra N. Miceli RT, et al. J Extracell Vesicles. 2024 Dec;13(12):e70005. doi: 10.1002/jev2.70005. J Extracell Vesicles. 2024. PMID: 39625409 Free PMC article. Review.
Comparing epidemiological and clinical data from RPS patients documented in a German cancer registry to a cohort from TARPSWG reference centres.
Neemann F, Jansen L, Hermann S, Silcher C, Hettler M, Hohenberger P, Callegaro D, Gronchi A, Fiore M, Miceli R, Van Coevorden F, Van Houdt W, Bonvalot S, Rutkowski P, Skoczylas J, Swallow CJ, Gladdy R, Strauss DC, Hayes A, Fairweather M, Raut CP, Jakob J. Neemann F, et al. Among authors: miceli r. J Cancer Res Clin Oncol. 2024 Nov 28;150(12):514. doi: 10.1007/s00432-024-06033-5. J Cancer Res Clin Oncol. 2024. PMID: 39604531 Free PMC article.
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, Giuliani F, Morano F, Niger M, Raimondi A, Prisciandaro M, Pircher CC, Sciortino C, Marchesi S, Garattini SK, Airò G, Miceli R, Di Bartolomeo M, Pietrantonio F. Randon G, et al. Among authors: miceli r. Lancet Oncol. 2024 Dec;25(12):1539-1550. doi: 10.1016/S1470-2045(24)00580-1. Epub 2024 Nov 15. Lancet Oncol. 2024. PMID: 39557058 Clinical Trial.
Radiomic features of primary retroperitoneal sarcomas: a prognostic study.
Pasquali S, Iadecola S, Vanzulli A, Infante G, Bologna M, Corino V, Greco G, Vigorito R, Morosi C, Beretta A, Percio S, Vallacchi V, Collini P, Sanfilippo R, Fabbroni C, Stacchiotti S, Fiore M, Huang P, Benelli M, Mainardi L, Miceli R, Gronchi A, Callegaro D. Pasquali S, et al. Among authors: miceli r. Eur J Cancer. 2024 Dec;213:115120. doi: 10.1016/j.ejca.2024.115120. Epub 2024 Nov 9. Eur J Cancer. 2024. PMID: 39541785 Free article.
Local Recurrence and Survival in Patients With Melanoma >2 mm in Thickness at Difficult Sites Treated With 1-cm Versus 2-cm Margins.
Maurichi A, Barretta F, Patuzzo R, Gallino G, Mattavelli I, Shimonovitz-Moore M, Nizri E, Matteucci M, Summo V, Cossa M, Valeri B, Cortinovis U, Miceli R, Santinami M. Maurichi A, et al. Among authors: miceli r. J Natl Compr Canc Netw. 2024 Nov 13;22(10):687-693. doi: 10.6004/jnccn.2024.7040. J Natl Compr Canc Netw. 2024. PMID: 39536446
448 results